Acelyrin is a biopharma company that invests in, develops and commercializes life-changing innovative therapeutics and transformative medicines. Acelyrin partners with big pharmaceutical companies, early-stage startups, and academia with a blend of scientific, medical, operational, and company-building experience to bring its treatments and therapeutics to the public, and transform patient's lives through healing and wellbeing.

Register for Details

For more details on financing and valuation for Acelyrin, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Acelyrin's ticker symbol?

Acelyrin does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Acelyrin's stock price?

The stock price for Acelyrin will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Acelyrin's major investors?

Cowen Group
Marshall Wace
Matrix Partners
Decheng Capital
Westlake Village BioPartners
OrbiMed Healthcare Fund Management
Samsara Biocapital
venBio
RTW Investments
Surveyor
Tybourne Capital Management

Acelyrin Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/9/2022 Series C $300MM raised $XXX.XX $XXX.XX
11/16/2021 Series B $250MM raised $XXX.XX $XXX.XX
12/15/2020 Series A $8MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Acelyrin

Forge green plus iconForge green minus icon

What is Acelyrin funding to date?

Acelyrin has raised $558MM to date.
Forge green plus iconForge green minus icon

When was Acelyrin founded?

Acelyrin was founded in 2020.
Forge green plus iconForge green minus icon

Can you invest in Acelyrin?

Acelyrin is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Acelyrin share pre-IPO?

If you own Acelyrin pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Acelyrin a publicly traded company?

Acelyrin is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Acelyrin in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Updated on: Sep 14, 2022